Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
China to promote centralised medicine procurement, use to ease patients' burden
20 November 2019 - China will improve its mechanism for centralized medicine procurement and use in a steady and orderly ...
Posted by Michael Wonder on 14 Nov 2019
Health products portal – intent to apply
14 November 2019 - The Department of Health (the Department) has been working to digitise and simplify the PBS submission ...
Posted by Michael Wonder on 14 Nov 2019
PHARMAC widening access to the meningococcal ACWY vaccine
14 November 2019 - The meningococcal ACWY vaccine will be available free from next month for young people in close ...
Posted by Michael Wonder on 14 Nov 2019
Watched by Apple
14 November 2019 - After taking over media, social communication, and the consumer economy, the forces of digital innovation are moving ...
Posted by Michael Wonder on 14 Nov 2019
10 year update on study results submitted to ClinicalTrials.gov
14 November 2019 - A decade after ClinicalTrials.gov launched a database for reporting results of clinical trials, the database includes results ...
Posted by Michael Wonder on 13 Nov 2019
Regulators’ advice can make a difference for faster patient access to highly innovative therapies
12 November 2019 - Early dialogue and frequent interactions between medicine developers, regulators, health technology assessment bodies and patients can play ...
Posted by Michael Wonder on 13 Nov 2019
13% of Americans say they know someone who died after they couldn't afford health care, survey says
12 November 2019 - More than 13% of Americans -- about 34 million people -- say a friend or family ...
Posted by Michael Wonder on 13 Nov 2019
Clovis Oncology announces reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Italy
13 November 2019 - Rucaparib now reimbursed in several countries in Europe with additional countries to follow in 2020. ...
Posted by Michael Wonder on 13 Nov 2019
FDA’s Project Orbis may expand to Singapore and Switzerland
12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...
Posted by Michael Wonder on 13 Nov 2019
Viracta receives fast track designation for nanatinostat combination for the treatment of EBV-associated lymphomas
12 November 2019 - Viracta Therapeutic, announced today that the U.S. FDA has granted fast track designation for nanatinostat in ...
Posted by Michael Wonder on 13 Nov 2019
ICER seeks public input to guide selection of non-drug assessment topics for 2020
13 December 2019 - Suggestions for new topics and comments on initial list of potential topics are encouraged; input most helpful ...
Posted by Michael Wonder on 13 Nov 2019
NICE recommends Elmiron for bladder pain syndrome
13 November 2019 - NICE has recommended Consilient Health’s Elmiron (pentosan polysulfate sodium) for bladder pain syndrome. ...
Posted by Michael Wonder on 13 Nov 2019
Actelion withdraws regulatory filings to extend the indication of Opsumit (macitentan 10mg) in CTEPH
12 November 2019 - Actelion Pharmaceuticals has announced its decision to voluntarily withdraw the European and other health authority filings ...
Posted by Michael Wonder on 13 Nov 2019
Biden and Bloomberg are bigger threats to big pharma than Warren, analyst says
11 November 2019 - Warren’s proposals may fail to gain support, especially from Democrats in states with a large pharmaceutical industry ...
Posted by Michael Wonder on 13 Nov 2019
NICE during the pre-election period
12 November 2019 - As a public body, NICE is required to follow civil service principles on communicating during the lead ...
Posted by Michael Wonder on 13 Nov 2019
Allergan receives FDA qualified infectious disease product designation and fast track designation for ATM-AVI (aztreonam and avibactam) for antibiotic-resistant gram-negative infections
11 November 2019 - FDA QIDP and fast track designations signify significant milestones in Allergan commitment to addressing unmet medical needs ...